Glover said regulators need to be willing and able to help colleagues in other countries with things such as inspection plans and reports. He noted that in July, Canadian officials inspected a Canadian facility operated by the drugmaker Apotex. A month later, inspectors from another "major" country inspected the same plant in the same way. After the panel discussion, he suggested creating a universal form for reporting adverse medical events that would mesh with a secure database, accessible to regulators around the globe, to enhance efficiency and catch more problems.